GLP-1 drugs: what Illinois Medicaid paid

Q: Does a paid prescription mean Illinois Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Illinois Medicaid shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Illinois Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Illinois Medicaid’s payment record shows

In 2026Q1, the product Illinois Medicaid paid for most often was Mounjaro®, at 7,143 prescriptions⁷ of the 20,346 to 20,409^{1,7,13,19,25,37,43} across all 8 products, or 35 percent of the published count.

Illinois Medicaid itself reimbursed at least $19,567,494 for these products in the quarter, about $962 per prescription. Pharmacies were paid $20,724,698 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,295.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Illinois Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Illinois Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Illinois Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Illinois Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	753¹	4%	$786,216	$787,034	$1,044
tirzepatideMounjaro®	Both6,513 managed care, 630 direct	at least 7,143⁷	35%	$7,582,795	$8,244,607	$1,062
semaglutideWegovy®	Managed care	at least 254¹³	1%	$328,956	$328,956	$1,295
semaglutideOzempic®	Both4,186 managed care, 415 direct	4,601¹⁹	23%	$4,621,108	$5,055,341	$1,004
semaglutideRybelsus®	Both4,558 managed care, 172 direct	4,730²⁵	23%	$5,101,000	$5,157,638	$1,078
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	at least 126³⁷	<1%	$96,758	$96,758	$768
liraglutideliraglutide (generic)	Both2,596 managed care, 136 direct	at least 2,732⁴³	13%	$1,050,661	$1,054,364	$385

Illinois Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were higher in 2026Q1 than in 2021Q1: 4,601 against 1,232. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 7.6 prescriptions per thousand people enrolled in Illinois Medicaid, on an average of 2,686,717 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 23 of the 168 product-quarters it holds a row for here, which is 14 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Illinois Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Illinois Medicaid paid for each product, quarter by quarter

Prescriptions Illinois Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®range 622 to 948, down 195 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	at least 64 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$66,982 paid	at least 303 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$315,445 paid	622 paid prescriptions in the quarter (2025Q3)²Count$655,389 paid	948 paid prescriptions in the quarter (2025Q4)²Count$994,088 paid	753 paid prescriptions in the quarter (2026Q1)¹Count$786,216 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	at least 59 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$64,570 paid	at least 247 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$198,844 paid	at least 571 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$493,252 paid	at least 801 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$766,202 paid	at least 1,314 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$1,281,222 paid	at least 1,865 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$1,790,165 paid	at least 2,804 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$3,074,787 paid	at least 4,219 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$4,657,743 paid	at least 5,648 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$6,266,762 paid	at least 6,675 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$7,543,251 paid	at least 7,770 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$8,620,329 paid	8,286 paid prescriptions in the quarter (2025Q2)⁸Count$8,889,609 paid	at least 8,883 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$9,606,373 paid	at least 9,496 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$10,092,888 paid	at least 7,143 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$7,582,795 paid
semaglutideWegovy®range 213 to 354	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld4 of 4 product codes withheld	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable¹⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable¹⁵Withheld3 of 3 product codes withheld	at least 53 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$68,760 paid	at least 125 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$161,823 paid	213 paid prescriptions in the quarter (2025Q1)¹⁴Count$283,441 paid	at least 266 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$346,879 paid	276 paid prescriptions in the quarter (2025Q3)¹⁴Count$362,364 paid	354 paid prescriptions in the quarter (2025Q4)¹⁴Count$460,322 paid	at least 254 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$328,956 paid
semaglutideOzempic®range 1,232 to 4,601	1,232 paid prescriptions in the quarter (2021Q1)²⁴Count$1,171,914 paid	1,369 paid prescriptions in the quarter (2021Q2)²⁴Count$1,394,304 paid	1,769 paid prescriptions in the quarter (2021Q3)²⁴Count$1,877,421 paid	at least 2,368 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$2,704,675 paid	at least 2,398 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$3,324,026 paid	at least 2,146 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$2,299,085 paid	at least 2,712 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$2,920,611 paid	at least 2,846 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$2,927,144 paid	at least 3,375 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$3,431,722 paid	at least 2,181 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$1,694,946 paid	at least 2,771 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$2,376,791 paid	at least 2,618 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$2,440,639 paid	at least 3,711 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$3,944,929 paid	at least 6,636 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$6,924,009 paid	at least 7,929 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$8,381,315 paid	at least 8,208 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$8,799,079 paid	at least 8,460 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$9,120,144 paid	at least 7,874 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$7,953,856 paid	at least 7,372 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$7,332,941 paid	at least 6,850 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$6,874,489 paid	4,601 paid prescriptions in the quarter (2026Q1)¹⁹Count$4,621,108 paid
semaglutideRybelsus®range 4,730 to 6,002, down 1,023 on the quarter before	at least 80 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$58,910 paid	at least 127 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$121,060 paid	at least 198 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$220,478 paid	at least 291 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$408,450 paid	at least 814 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$1,150,531 paid	at least 1,205 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$1,450,881 paid	at least 1,776 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$2,143,669 paid	at least 2,238 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$2,732,125 paid	at least 3,071 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$3,753,255 paid	at least 3,485 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$3,917,525 paid	at least 4,213 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$4,834,616 paid	at least 4,455 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$5,237,509 paid	at least 4,917 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$5,826,143 paid	at least 6,397 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$7,490,609 paid	at least 6,635 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$7,697,801 paid	at least 6,222 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$7,196,761 paid	at least 6,078 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$7,333,967 paid	6,002 paid prescriptions in the quarter (2025Q2)²⁶Count$7,387,767 paid	5,829 paid prescriptions in the quarter (2025Q3)²⁶Count$7,188,043 paid	5,753 paid prescriptions in the quarter (2025Q4)²⁶Count$6,556,879 paid	4,730 paid prescriptions in the quarter (2026Q1)²⁵Count$5,101,000 paid
liraglutideSaxenda®	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 2,879 to 18,240	13,390 paid prescriptions in the quarter (2021Q1)⁴²Count$14,069,736 paid	14,835 paid prescriptions in the quarter (2021Q2)⁴²Count$15,854,995 paid	18,005 paid prescriptions in the quarter (2021Q3)⁴²Count$19,951,881 paid	18,240 paid prescriptions in the quarter (2021Q4)⁴²Count$20,580,816 paid	17,079 paid prescriptions in the quarter (2022Q1)⁴¹Count$20,755,182 paid	14,929 paid prescriptions in the quarter (2022Q2)⁴¹Count$16,600,507 paid	15,327 paid prescriptions in the quarter (2022Q3)⁴¹Count$17,100,639 paid	14,320 paid prescriptions in the quarter (2022Q4)⁴¹Count$16,161,308 paid	14,904 paid prescriptions in the quarter (2023Q1)⁴⁰Count$16,898,276 paid	13,974 paid prescriptions in the quarter (2023Q2)⁴⁰Count$15,544,500 paid	12,774 paid prescriptions in the quarter (2023Q3)⁴⁰Count$13,924,692 paid	11,098 paid prescriptions in the quarter (2023Q4)⁴⁰Count$12,007,938 paid	9,686 paid prescriptions in the quarter (2024Q1)³⁹Count$8,131,526 paid	8,183 paid prescriptions in the quarter (2024Q2)³⁹Count$6,573,831 paid	5,138 paid prescriptions in the quarter (2024Q3)³⁹Count$4,085,119 paid	2,879 paid prescriptions in the quarter (2024Q4)³⁹Count$2,357,740 paid	at least 923 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$714,015 paid	at least 152 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³⁸At least$125,007 paid	at least 163 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld³⁸At least$127,265 paid	at least 179 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld³⁸At least$136,789 paid	at least 126 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld³⁷At least$96,758 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld1 of 1 product codes withheld	392 paid prescriptions in the quarter (2024Q3)⁴⁵Count$238,512 paid	at least 2,093 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$1,221,861 paid	at least 3,493 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$2,080,866 paid	at least 4,482 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$2,253,487 paid	at least 4,393 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$2,011,112 paid	at least 4,146 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$1,639,676 paid	at least 2,732 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$1,050,661 paid

What this page cannot tell you

Whether Illinois Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Illinois in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, IL
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state IL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "212"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, IL
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state IL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "295"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, IL
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state IL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, IL
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state IL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "product_name": "product_name like ZEPBOUND%, state IL, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, IL
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state IL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "product_name": "product_name like ZEPBOUND%, state IL, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, IL
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state IL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "product_name": "product_name like ZEPBOUND%, state IL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, IL
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state IL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 1", "suppression_used": "false", "number_of_prescriptions": "1414"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, IL
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state IL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 1", "suppression_used": "false", "number_of_prescriptions": "1837"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, IL
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state IL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1292"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, IL
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state IL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "442"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, IL
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state IL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "95"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, IL
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state IL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "product_name": "product_name like MOUNJARO%, state IL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, IL
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state IL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "66"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, IL
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state IL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "90"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, IL
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state IL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "46"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, IL
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state IL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1.7", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, IL
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state IL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2022", "quarter": "2", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, IL
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state IL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.5", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, IL
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state IL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "1975"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, IL
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state IL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "3025"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, IL
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state IL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2541"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, IL
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state IL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1167"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, IL
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state IL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "1173"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, IL
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state IL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1147"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, IL
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state IL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "1878"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, IL
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state IL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "2407"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, IL
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state IL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "2646"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, IL
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state IL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "1987"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, IL
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state IL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "1048"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, IL
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state IL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "98"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, IL
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state IL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IL", "product_name": "product_name like SAXENDA%, state IL, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, IL
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state IL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, IL
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state IL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "product_name": "product_name like SAXENDA%, state IL, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, IL
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state IL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, IL
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state IL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, IL
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state IL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, IL
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state IL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "72"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, IL
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state IL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "570"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, IL
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state IL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "5224"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, IL
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state IL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "8184"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, IL
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state IL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "9850"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, IL
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state IL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "10439"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, IL
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state IL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "IL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "746"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, IL
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state IL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "1790"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, IL
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state IL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "1096"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, IL
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state IL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "product_name": "product_name like LIRAGLUTID%, state IL, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, IL
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state IL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "product_name": "product_name like LIRAGLUTID%, state IL, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, IL
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state IL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "IL", "product_name": "product_name like LIRAGLUTID%, state IL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 39 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 9 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Illinois Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.